Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts. - Jahan, Farhana; Penna, Leena; Luostarinen, Annu; Veltman, Laurens; Hongisto, Heidi; Lähteenmäki, Kaarina; Müller, Sabine; Ylä-Herttuala, Seppo; Korhonen, Matti; Vettenranta, Kim; Laitinen, Anita; Salmenniemi, Urpu; et al. (Scientific Reports, 2024)